Study on absorption sites of quinidine and methotrexate in rat intestine

Pharmazie

Volumn 65, Issue 6, 2010, Pages 440-447

  Murakami, Teruo ^a   Yokooji, T ^a   Mori, N ^a  

^a HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; GLYCOPROTEIN P; METHOTREXATE; PROTON COUPLED FOLATE TRANSPORTER; QUINIDINE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; CARRIER PROTEIN; DEXTRAN; DRUG DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; FOLIC ACID ANTAGONIST;

ACIDITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFECT; DUODENUM; ILEUM; INTESTINE ABSORPTION; INTESTINE PRESSURE; JEJUNUM; NONHUMAN; PROTEIN EXPRESSION; PROTON TRANSPORT; RAT; STOMACH; STOMACH EMPTYING; ANIMAL; BIOAVAILABILITY; MALE; METABOLISM; MOLECULAR WEIGHT; ORAL DRUG ADMINISTRATION; PH; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIMALARIALS; BIOLOGICAL AVAILABILITY; CARRIER PROTEINS; DEXTRANS; DUODENUM; FLUORESCEIN-5-ISOTHIOCYANATE; FOLIC ACID ANTAGONISTS; GASTRIC EMPTYING; HYDROGEN-ION CONCENTRATION; ILEUM; INTESTINAL ABSORPTION; JEJUNUM; MALE; METHOTREXATE; MOLECULAR WEIGHT; QUINIDINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77955288210     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.0031R     Document Type: Article

References (62)

1. Ahmed IS, Ayres JW (2007) Bioavailability of riboflavin from a gastric retention formulation. Int J Pharm 330: 146-154.
2. Amidon GL, Lennernas H, Shah VP, Crison JR (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12: 413-420.
3. Anthone GJ, Barry MK, Yeo CJ (1993) Site specificity and meal stimulation of the intestinal absorption ofwater, electrolytes, and bile acids. Am J Surg 165: 704-707.
4. Anthone GJ, Wang BH, Zinner MJ, Yeo CJ (1992) Site-specific variations in basal and meal-stimulated intestinal absorption. J Surg Res 52: 454-458.
5. Bronner F (2003) Mechanisms of intestinal calcium absorption. J Cell Biochem 88: 387-393.
6. Castell DO, Murray JA, Tutuian R, Orlando RC, Arnold R (2004) Review article: the pathophysiology of gastro-oesophageal reflux disease - oesophageal manifestations. Aliment Pharmacol Ther 9: 14-25.
7. Dahan A, Amidon GL (2009) Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Mol Pharm 6: 19-28.
8. Djaldetti R, Ziv I, Melamed E (1996) Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's disease. Isr J Med Sci 32: 1224-1227.
9. Emi Y, Tsunashima D, Ogawara K, Higaki K, Kimura T (1998) Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine. J Pharm Sci 87: 295-299.
10. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD (1988) Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29: 1035-1041.
11. Gispen JG, Alarcón GS, Johnson JJ, Acton RT, Barger BO, Koopman WJ (1987) Toxicity of methotrexate in rheumatoid arthritis. J Rheumatol 14: 74-79.
12. Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, Zundler J, Kroemer HK (1999) The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 104: 147-153.
13. Hamdani J, Goole J, Moës AJ, Amighi K (2006) In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process. Int J Pharm 323: 86-92.
14. Hamilton RA, Kremer JM (1995) The effects of food on methotrexate absorption. J Rheumatol 22: 630-632.
15. Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, Honigman S, Giladi N (2001) Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 16: 1041-1047.
16. Hewitt RR, Levy G (1971) Effect of viscosity on thiamine and riboflavin absorption in man. J Pharm Sci 60: 784-786.
17. Ho GT, Moodie FM, Satsangi J (2003) Multidrug resistance 1 gene (Pglycoprotein 170): an important determinant in gastrointestinal disease? Gut 52: 759-766.
18. Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M (2004) Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. J Rheumatol 31: 645-648.
19. Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M (2006) Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis. J Rheumatol 33: 481-485.
20. Inoue K, Nakai Y, Ueda S, Kamigaso S, Ohta KY, Hatakeyama M, Hayashi Y, Otagiri M, Yuasa H (2008) Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model. Am J Physiol Gastrointest Liver Physiol 294: G660-668.
21. Kagan L, Lapidot N, Afargan M, Kirmayer D, Moor E, Mardor Y, Friedman M, Hoffman A (2006) Gastroretentive accordion pill: enhancement of riboflavin bioavailability in humans. J Control Release 113: 208-215.
22. Kaneniwa N, Funaki T, Furuta S, Watari N (1986) Study of the absorption site of cimetidine. J Pharmacobiodyn 9: 321-326.
23. Katoh M, Suzuyama N, Takeuchi T, Yoshitomi S, Asahi S, Yokoi T (2006) Kinetic analyses for species differences in P-glycoprotein-mediated drug transport. J Pharm Sci 95:2673-2683.
24. Kusuhara H, Suzuki H, Terasaki T, Kakee A, Lemaire M, Sugiyama Y (1997) P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier. J Pharmacol Exp Ther 283: 574-580.
25. Kramer W, Girbig F, Gutjahr U, Kowalewski S, Jouvenal K, Müller G, Tripier D, Wess G (1993) Intestinal bile acid absorption. Na(+)-dependent bile acid transport activity in rabbit small intestine correlates with the coexpression of an integral 93-kDa and a peripheral 14-kDa bile acid-binding membrane protein along the duodenum-ileum axis. J Biol Chem 268: 18035-18046.
26. Kremer JM, Lee JK (1988) A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months. Arthritis Rheum 31: 577-584.
27. Lack L (1979) Properties and biological significance of the ileal bile salt transport system. Environ Health Perspect. 33: 79-89.
28. Lebbe C, Beyeler C, Gerber NJ, Reichen J (1994) Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis. Ann Rheum Dis 53: 475-477.
29. Levy G, Jusko WJ (1966) Factors affecting the absorption of riboflavin in man. J Pharm Sci 55: 285-289.
30. Lindahl A, Sandström R, Ungell AL, Lennernäs H (1998) Concentration-and region-dependent intestinal permeability of fluvastatin in the rat. J Pharm Pharmacol 50: 737-744.
31. Lindahl A, Sjöberg A, Bredberg U, Toreson H, Ungell AL, Lennernäs H (2004) Regional intestinal absorption and biliary excretion of fluvastatin in the rat: possible involvement of mrp2. Mol Pharm 1: 347-356.
32. Lown KS, Mayo RR, Leichtman AB, Hsiao HL, Turgeon DK, Schmiedlin-Ren P, Brown MB, Guo W, Rossi SJ, Benet LZ, Watkins PB (1997) Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 62: 248-260.
33. Makhey VD, Guo A, Norris DA, Hu P, Yan J, Sinko PJ (1998) Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res 15: 1160-1167.
34. Masuda S, Uemoto S, Hashida T, Inomata Y, Tanaka K, Inui K (2000) Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient. Clin Pharmacol Ther 68: 98-103.
35. McClintock C, Shiau YF (1983) Jejunum is more important than terminal ileum for taurocholate absorption in rats. Am J Physiol 244: G507-514.
36. Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y (2003) Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 55: 425-461.
37. Müller M, Mayer R, Hero U, Keppler D (1994) ATP-dependent transport of amphiphilic cations across the hepatocyte canalicular membrane mediated by mdr1 P-glycoprotein. FEBS Lett 343: 168-172.
38. Murakami T, Takano M (2008) Intestinal efflux transporters and drug absorption. Expert Opin Drug Metab Toxicol 4: 923-939.
39. Murry DJ, Synold TW, Pui CH, Rodman JH (1995) Renal function and methotrexate clearance in children with newly diagnosed leukemia. Pharmacotherapy 15: 144-149.
40. Mouly S, Paine MF (2003) P-glycoprotein increases from proximal to distal regions of human small intestine. Pharm Res 20: 1595-1599.
41. Mori N, Yokooji T, Murakami T (2008) Fate of quinidine, a P-glycoprotein substrate, in the gastrointestinal tract after oral administration in rats. Pharmazie 63: 241-244.
42. Nakai Y, Inoue K, Abe N, Hatakeyama M, Ohta KY, Otagiri M, Hayashi Y, Yuasa H (2007) Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter. J Pharmacol Exp Ther 322: 469-476.
43. Nakashima T, Seto Y, Nakajima T, Shima T, Sakamoto Y, Sano A, Takino T (1989) Distribution of tissue bile acids in the human alimentary tract and colon polyps. Jpn J Med 28: 25-29.
44. Nyholm D, Lennernäs H (2008) Irregular gastrointestinal drug absorption in Parkinson's disease. Expert Opin Drug Metab Toxicol 4: 193-203.
45. Oguey D, Kölliker F, Gerber NJ, Reichen J (1992) Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 35: 611-614.
46. Pohle T, Domschke W (2003) Gastric function measurements in drug development. Br J Clin Pharmacol 56: 156-164.
47. Sklan D, Trostler N (1977) Site and extent of thiamin absorption in the rat. J Nutr. 107:353-356.
48. Stephens RH, O'Neill CA, Warhurst A, Carlson GL, Rowland M, Warhurst G (2001) Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J Pharmacol Exp Ther 296: 584-591.
49. Suttle AB, Brouwer KL (1995) Regional gastrointestinal absorption of ranitidine in the rat. Pharm Res 12: 1311-1315.
50. Suzuyama N, Katoh M, Takeuchi T, Yoshitomi S, Higuchi T, Asashi S, Yokoi T (2007) Species differences of inhibitory effects on P-glycoprotein-mediated drug transport. J Pharm Sci 96: 1609-1618.
51. Swierkot J, Szechiński J (2006) Methotrexate in rheumatoid arthritis. Pharmacol Rep 58: 473-492.
52. Takano M, Yumoto R, Murakami T (2006) Expression and function of efflux drug transporters in the intestine. Pharmacol Ther 109: 137-1361.
53. Takeuchi T, Yoshitomi S, Higuchi T, Ikemoto K, Niwa S, Ebihara T, Katoh M, Yokoi T, Asahi S (2006) Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1. Pharm Res. 23:1460-1472.
54. Tomei S, Yuasa H, Inoue K, Watanabe J (2001) Transport functions of riboflavin carriers in the rat small intestine and colon: site difference and effects of tricyclic-type drugs. Drug Deliv 8:119-124.
55. Varma MV, Panchagnula R (2005) pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ. J Pharm Sci 94: 2632-2643.
56. von Richter O, Burk O, Fromm MF, Thon KP, Eichelbaum M, Kivistö KT (2004) Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther 75: 172-183.
57. Wu CY, Benet LZ (2005) Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 22: 11-23.
58. Yokooji T, Murakami T, Yumoto R, Nagai J, Takano M (2007) Role of intestinal efflux transporters in the intestinal absorption of methotrexate in rats. J Pharm Pharmacol 59: 1263-1270.
59. Yokooji T, Mori N, Murakami T (2009) Site-specific contribution of proton-coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats. J Pharm Pharmacol 61: 911-918.
60. Yuasa H, Hirobe M, Tomei S, Watanabe J (2000) Carrier-mediated transport of riboflavin in the rat colon. Biopharm Drug Dispos 21: 77-82.
61. Yuasa H, Inoue K, Hayashi Y (2009) Molecular and functional characteristics of proton-coupled folate transporter. J Pharm Sci 98: 1608-1616.
62. Yumoto R, Murakami T, Nakamoto Y, Hasegawa R, Nagai J, Takano M (1999) Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds. J Pharmacol Exp Ther 289: 149-155.